BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15711802)

  • 1. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
    Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in beta-thalassemia.
    Aessopos A; Farmakis D
    Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic assessment of splenomegaly in beta-thalassemia patients undergoing splenectomy.
    Aessopos A; Farmakis D; Tsironi M; Deftereos S; Tassiopoulos S; Konstantopoulos K; Rombos J; Papalambros E
    Ann Hematol; 2004 Dec; 83(12):775-8. PubMed ID: 15338197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.
    Karimi M; Borzouee M; Mehrabani A; Cohan N
    Eur J Haematol; 2009 Mar; 82(3):213-8. PubMed ID: 19077048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Tassiopoulos S; Moyssakis I; Karagiorga M
    Chest; 2005 May; 127(5):1523-30. PubMed ID: 15888823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Functions in Children With Thalassemia Major.
    Ozyoruk D; Misirlioglu ED
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):605-10. PubMed ID: 26422288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extramedullary Hematopoiesis in β-Thalassemia.
    Kalchiem-Dekel O; Greenbaum U
    Mayo Clin Proc; 2015 Nov; 90(11):1591-2. PubMed ID: 26541258
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramedullary hematopoiesis-related pleural effusion: the case of beta-thalassemia.
    Aessopos A; Tassiopoulos S; Farmakis D; Moyssakis I; Kati M; Polonifi K; Tsironi M
    Ann Thorac Surg; 2006 Jun; 81(6):2037-43. PubMed ID: 16731126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac involvement in thalassemia intermedia: a multicenter study.
    Aessopos A; Farmakis D; Karagiorga M; Voskaridou E; Loutradi A; Hatziliami A; Joussef J; Rombos J; Loukopoulos D
    Blood; 2001 Jun; 97(11):3411-6. PubMed ID: 11369631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
    Abdulwahid DA; Hassan MK
    Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.
    Aessopos A; Kati M; Farmakis D
    Haematologica; 2007 May; 92(5):658-65. PubMed ID: 17488690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary approaches to treatment of beta-thalassemia intermedia.
    Taher AT; Musallam KM; Karimi M; Cappellini MD
    Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients.
    Liguori C; Pitocco F; Di Giampietro I; De Vivo AE; Schena E; Giurazza F; Sorrentino F; Zobel BB
    Biomed Res Int; 2015; 2015():857642. PubMed ID: 25922841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-thalassemia and pulmonary function.
    Piatti G; Allegra L; Ambrosetti U; Cappellini MD; Turati F; Fiorelli G
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiography in thalassemic patients on blood transfusions and chelation without heart failure.
    Rodrigues A; Guimarães-Filho FV; Braga JC; Rodrigues CS; Waib P; Fabron-Junior A; Tan DM; França AC; Okoshi MP; Okoshi K
    Arq Bras Cardiol; 2013 Jan; 100(1):75-81. PubMed ID: 23295250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.